Takeda Pharmaceutical
Bob G. Schultz, PharmD, MS, serves as the Director of Value & Evidence Generation at Takeda, where previous roles include Associate Director and Lead of the IGNITE (Diversity, Equity, and Inclusion) initiative. In addition to industry experience, Bob is an Adjunct Professor at Regis University and has contributed to health economics and outcomes research as a fellow at the University of Illinois at Chicago. Bob has also been involved with the Institutional Economic Modeling Team at the Institute for Clinical and Economic Review.
This person is not in any teams
This person is not in any offices
Takeda Pharmaceutical
178 followers
For more than 230 years, Takeda has brought hope to people around the world through its people-centered and innovation-driven approach to science and medicine. As a global pharmaceutical leader, Takeda focuses on solving unmet needs where it can make a real difference—and on putting patients first. Its therapeutics focus is oncology, gastroenterology, and the central nervous system, as well as vaccines.